Literature DB >> 19058321

Gastric carcinoid tumor in a patient with a past history of gastrointestinal stromal tumor of the stomach.

Chien-Yuan Hung1, Ming-Jen Chen, Shou-Chuan Shih, Tsang-Pai Liu, Yu-Jan Chan, Tsang-En Wang, Wen-Hsiung Chang.   

Abstract

Gastrointestinal stromal tumor is the most common mesenchymal tumor in the gastrointestinal tract. It may coexist with other type of cancers, and if so, the tumors usually involve the stomach. The most common associated cancers are gastrointestinal carcinomas. We report a 65-year-old woman with a history of gastric gastrointestinal stromal tumor who had undergone subtotal segmental gastrectomy. New polypoid lesions were detected on a follow-up gastroscopy one year later. The lesions were biopsied and found to be carcinoid tumors. There was serum hypergastrinemia, and type 1 gastric carcinoid tumor was diagnosed. A total gastrectomy was performed. Pathologic examination revealed both carcinoid tumors and a recurrent gastrointestinal stromal tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19058321      PMCID: PMC2773889          DOI: 10.3748/wjg.14.6884

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Carcinoid tumors of the duodenum.

Authors:  John T Mullen; Huamin Wang; James C Yao; Jeffrey H Lee; Nancy D Perrier; Peter W T Pisters; Jeffrey E Lee; Douglas B Evans
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

Review 3.  Occurrence of other malignancies in patients with gastrointestinal stromal tumors.

Authors:  Abbas Agaimy; Peter H Wünsch; Leslie H Sobin; Jerzy Lasota; Markku Miettinen
Journal:  Semin Diagn Pathol       Date:  2006-05       Impact factor: 3.464

4.  [Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms].

Authors:  Erika Kövér; Zsolt Faluhelyi; Barna Bogner; Katalin Kalmár; Gábor Horváth; Tamás Tornóczky
Journal:  Magy Onkol       Date:  2005-01-17

5.  [Comparison and analysis of the clinical features of different types of gastrointestinal cancers].

Authors:  Yi-qun Hu; Jia-ming Qian; Xu-dong Zhou
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2004-12

6.  Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type.

Authors:  Kurt Borch; Bo Ahrén; Håkan Ahlman; Sture Falkmer; Göran Granérus; Lars Grimelius
Journal:  Ann Surg       Date:  2005-07       Impact factor: 12.969

7.  Endoscopic mucosal resection in the management of gastric carcinoid tumors.

Authors:  J Ichikawa; S Tanabe; W Koizumi; Y Kida; H Imaizumi; M Kida; K Saigenji; H Mitomi
Journal:  Endoscopy       Date:  2003-03       Impact factor: 10.093

8.  A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem?

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Am J Gastroenterol       Date:  2004-01       Impact factor: 10.864

9.  Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia.

Authors:  D B Gough; G B Thompson; T B Crotty; J H Donohue; L K Kvols; J A Carney; C S Grant; D M Nagorney
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

10.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

View more
  1 in total

Review 1.  Synchronous well differentiated neuroendocrine tumour and gastrointestinal stromal tumour of the stomach: a case report.

Authors:  Vassilis D Samaras; Periklis G Foukas; Konstantinos Triantafyllou; Vassilia Leontara; Dimitrios Tsapralis; Eirini M Tsompanidi; Anastasios Machairas; Ioannis G Panayiotides
Journal:  BMC Gastroenterol       Date:  2011-03-24       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.